Dimensional Fund Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11M Buy
212,889
+170,405
+401% +$8.65M ﹤0.01% 2242
2026
Q2
$1.54M Buy
+42,484
New +$1.25M ﹤0.01% 2792
2024
Q3
– Sell
-10,564
Closed -$34.8K – 3364
2024
Q2
$34.8K Hold
10,564
– – ﹤0.01% 3336
2024
Q1
$39.6K Hold
10,564
– – ﹤0.01% 3341
2023
Q4
$46.3K Buy
+10,564
New +$42.4K ﹤0.01% 3354

Other funds holding ETON

Dimensional Fund Advisors's ETON Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Eton Pharmaceutcials (ETON) stake by 401% in Q3 2026, buying an estimated $8.65M and bringing the position to 212,889 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

Dimensional Fund Advisors first reported a position in ETON in Q4 2023 and has held it in 5 quarters since. 66 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Dimensional Fund Advisors held 212,889 shares of Eton Pharmaceutcials worth $11M as of Q3 2026.
  • Dimensional Fund Advisors bought 170,405 Eton Pharmaceutcials shares in Q3 2026, an estimated $8.65M.
  • Eton Pharmaceutcials made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2242 holding.
  • Dimensional Fund Advisors first reported a position in Eton Pharmaceutcials in Q4 2023 and has held it in 5 quarters since.
  • 66 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.